Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04835415
Other study ID # 6777
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 10, 2021
Est. completion date December 1, 2021

Study information

Verified date January 2022
Source Zagazig University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to evaluate analgesic effect of ultrasound-guided retrolaminar block vs ultrasound-guided thoracic epidural analgesia in pain control following laparoscopic cholecystectomy.


Description:

To study the difference between the effects of ultrasound-guided bilateral retrolaminar block and ultrasound-guided thoracic epidural analgesia on pain control following laparoscopic cholecystectomy. To relief pain and improve satisfaction in patients undergoing laparoscopic cholecystectomy at Zagazig university hospitals.


Recruitment information / eligibility

Status Completed
Enrollment 52
Est. completion date December 1, 2021
Est. primary completion date November 15, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years to 45 Years
Eligibility Inclusion Criteria: - Written informed consent from the patient. - Age: 21-45 years old. - Sex: both sex (males and females). - Physical status: ASA 1& II. - BMI = (25-35 kg/m2). - Type of operation: elective laparoscopic cholecystectomy Exclusion Criteria: - Altered mental state. - Patients with known history of allergy to study drugs. - Advanced hepatic, renal, cardiovascular, and respiratory diseases. - Patients with chronic pain. - Patients receiving anticoagulants. - Contraindications of regional anesthesia, e.g., allergy to local anesthetics, coagulopathy, or septic focus at site of injection.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Bilateral retrolaminar block
in lateral position and after skin sterilization. The spine is palpated from cervical (C7) downward toT7 and point marked to identify the spinous process. The linear high frequency transducer (6-13 MHz) will be placed parasagittal plane 1 cm lateral to the midline. The needle (18 gauge) is inserted in the plane view of the ultrasound probe to target the T7 and needle is advanced from downward to upward until the needle tip contacted the lamina. After negative aspiration, a 20 ml of bupivacaine 0.25 % plus 5ug/ml adrenaline (1:200000) will be injected. The procedure will be repeated following the same steps on the other side.
Thoracic epidural analgesia
In the lateral position, after skin sterilization, Ultrasound with high frequency linear probe (5-13 MHz). Thoracic intervertebral space (T7-8) will be identified by counting from the C7 to prominent thoracic spine (T7). The probe will be used in parasagittal plane 2 cm from midline. The probe will be directed medially to identify the dura matter at the T7-8 intervertebral space . the needle 18 gauage will be inserted in plane to target T7-8 intervertebral space ., after needle tip reached target space, loss of resistance technique then 20 ml bupivacaine 0.25% plus 5ug/ml adrenaline (1:200000) was injected after aspiration

Locations

Country Name City State
Egypt faculty of medicine, Zagazig university Zagazig

Sponsors (1)

Lead Sponsor Collaborator
Zagazig University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pain intensity at rest and at cough using Numerical Rating Scales (NRS) measured by NRS consisted of a series of numbers represents range of pain intensity (10 means the worst pain and 0 means no pain) 30 minutes postoperative
Primary Pain intensity at rest and at cough using Numerical Rating Scales (NRS) measured by NRS consisted of a series of numbers represents range of pain intensity (10 means the worst pain and 0 means no pain) at 1 hour postoperative
Primary Pain intensity at rest and at cough using Numerical Rating Scales (NRS) measured by NRS consisted of a series of numbers represents range of pain intensity (10 means the worst pain and 0 means no pain) at 2 hours postoperative
Primary Pain intensity at rest and at cough using Numerical Rating Scales (NRS) measured by NRS consisted of a series of numbers represents range of pain intensity (10 means the worst pain and 0 means no pain) at 4 hours postoperative
Primary Pain intensity at rest and at cough using Numerical Rating Scales (NRS) measured by NRS consisted of a series of numbers represents range of pain intensity (10 means the worst pain and 0 means no pain) at 6 hours postoperative
Primary Pain intensity at rest and at cough using Numerical Rating Scales (NRS) measured by NRS consisted of a series of numbers represents range of pain intensity (10 means the worst pain and 0 means no pain) at 8 hours postoperative
Primary Pain intensity at rest and at cough using Numerical Rating Scales (NRS) measured by NRS consisted of a series of numbers represents range of pain intensity (10 means the worst pain and 0 means no pain) at 10 hours postoperative
Primary Pain intensity at rest and at cough using Numerical Rating Scales (NRS) measured by NRS consisted of a series of numbers represents range of pain intensity (10 means the worst pain and 0 means no pain) at 12 hours postoperative
Secondary Time to first call of rescue analgesia start from retrolaminar or epidural injection of the drug to the time of first call of naluphine within 12 hours postoperative
Secondary Total analgesic (Naluphine) consumption Total consumption of rescue analgesia(Naluphine) post operative within 12 hours postoperative
Secondary The number of participant with complications of the techinque (dural puncture , nerve injury, spinal injection, epidural haematoma, pleural puncture) The numer of participant with complications of the techinque (dural puncture , nerve injury, spinal injection, epidural haematoma, pleural puncture) within 24 hours postoperative
Secondary Patient satisfaction is recorded at the end of 24 hours postoperative using 5-point Likert-like verbal rating scale by asking the patient about "how he/she evaluated their experience with the analgesic management after the surgery?"5=very satisfied, 4=satisfied, 3= neutral, 2= dissatisfied and 1= very dissatisfied". 24 hours postoperative
Secondary The number of participant with nausea, vomiting, hypotension and bradycardia. the number of participant with nausea (sensation of being about to vomit), vomiting (the expelling of the food content from the stomach through mouth, it will be treated by 4 mg ondansetron), hypotension (if MAP decreases more than 20% of basal reading it will be treated by 12 mg ephedrine) and bradycardia (if HR less than 50 beats/min it will be treated by 0.5 mg atropine). 24 hours postoperative
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05534230 - Dexmedetomidine for Pain Reduction in CABG N/A
Recruiting NCT06275698 - HONEY for the Treatment of POst-Tonsillectomy Pain N/A
Recruiting NCT04436224 - Hydromorphone for ICU-analgesia in Patients With Non-mechanical Ventilation Phase 4
Not yet recruiting NCT04548323 - Hypoalgesic Effects of Walking and Running Imagined
Completed NCT06054945 - Clinical Impact of IPACK Block Addition to Suprainguinal Fascia Iliaca Block
Completed NCT04394481 - Extension of Analgesia by Combined Injection of Dexamethasone and Dexmedetomidine After Arthroscopic Shoulder Surgery Phase 4
Completed NCT04690647 - The Efficacy of Suprainguinal Fascia Iliaca Compartment Block for Analgesia After Elective Total Hip Replacement. N/A
Completed NCT05034601 - ESPB vs TPVB for Postoperative Analgesia After the Nuss Procedure N/A
Completed NCT03740815 - Feasibility of Serratus Plane Block Associated With Sedation in Axillary Dissection N/A
Recruiting NCT05454202 - Assessment of the Interest of ANI in the Non-communicating Patient in Palliative Care
Recruiting NCT04554186 - Serratus Anterior Plane Block Versus Thoracic Paravertebral Block. N/A
Not yet recruiting NCT06393777 - Effectiveness of Pre-administered Natural Sweet-tasting Solution (Honey) for Decreasing Pain of Needle Insertion N/A
Suspended NCT04860635 - Safety of F14 Following Total Knee Replacement Phase 2/Phase 3
Not yet recruiting NCT04519463 - The Effect of Local Anesthesia With Lidocaine During Insertion and Removal of Nasal Packing Early Phase 1
Completed NCT02916342 - Interscalene Block Versus Combined Supraprascapular: Axillary Nerve Blocks Phase 4
Completed NCT03206554 - Local Infiltration Analgesia in Total Knee Arthroplasty Phase 2
Not yet recruiting NCT02549118 - Tenoxicam for Intrapartum Analgesia Phase 2
Not yet recruiting NCT02190760 - Comparison Between Perineural and Systemic Effect of Dexamethasone for Interscalene Brachial Plexus Block. N/A
Completed NCT01789606 - Self-Selection and Actual Use Trial of Ibuprofen 600 mg Immediate Release/Extended Caplet Phase 3
Completed NCT01299584 - ULTIVA Post Marketing Surveillance N/A